Diabetes: how to manage cardiovascular risk in secondary prevention patients

This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.